A novel Val734Ile variant in the ABCC9 gene associated with myocardial infarction

Piercarlo Minoretti1, Colomba Falcone, Alessia Aldeghi

  • 1Department of Cardiology, Alessandro Manzoni Hospital of Lecco, Lecco, Italy.

Insights

Genetic variations in the ABCC9 gene are linked to early myocardial infarction (MI). A specific ABCC9 mutation (734Ile allele) significantly increases the risk of MI before age 60.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetic Epidemiology

Background:

  • Coronary vasomotor tone alterations are implicated in myocardial infarction (MI).
  • The ATP-binding cassette transporter C9 (ABCC9) gene may regulate coronary artery vasomotility.
  • Investigating genetic variations in ABCC9 for association with early-onset MI is crucial.

Purpose of the Study:

  • To determine if genetic variations in the ABCC9 gene coding sequence are associated with precocious MI (myocardial infarction before age 60).

Main Methods:

  • Screening of the entire ABCC9 coding region using PCR-SSCP analysis in 45 precocious MI patients and 45 matched controls.
  • Analysis of a novel missense mutation (Val734Ile in exon 17) frequency using PCR-RFLPs in a larger Italian cohort (584 MI patients, 873 controls).
  • Multivariate logistic regression analysis adjusting for age, gender, and cardiovascular risk factors.

Main Results:

  • A novel missense mutation, Val734Ile in exon 17 of ABCC9, was identified in one MI patient.
  • Carriers of the rare 734Ile allele showed a 6.40-fold increased risk of MI before age 60 compared to controls (95% CI=1.58-25.90, P=0.009).
  • This association remained significant after adjusting for confounding factors.

Conclusions:

  • The study provides the first evidence linking the newly discovered 734Ile allele in the ABCC9 gene to an increased susceptibility to precocious MI in the studied population.
  • This genetic variant may play a role in the pathogenesis of early-onset myocardial infarction.
  • Further research is warranted to elucidate the functional mechanisms of ABCC9 in coronary artery disease.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...